Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Prithwish has close to 28 years of experience in a Commercial role
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Subscribe To Our Newsletter & Stay Updated
